Cardiol Therapeutics

Cardiol Therapeutics Inc. is a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease.

Industries

Biotechnology

Headquarters

Oakville, Canada

Stage

Post IPO Equity

Employees

11-50

Links

Org chart

David Elsley

President & CEO

Collapse

Bernard Lim

COO

Chris Waddick

CFO

Andrew Hamer

Chief Medical Officer & Head of Research & Development

John A. Geddes

VP of Business Development

Anne Tomalin

Director of Regulatory Affairs

Blagoja Ristevski

Director of Chemical Engineering & Manufacturing

Teams

View all

+10

Board of Directors

13 members

Leadership Team

6 members

CEO and Executive Team

4 members

Discover similar companies

Geneseeq Technology

Toronto, Canada · Series D

Medicenna Therapeutics

Toronto, Canada · Post IPO Equity

Zymeworks

Vancouver, Canada · Post IPO Equity

Evaxion Biotech

Copenhagen, Denmark · IPO

Tempus Labs

Chicago, United States · Debt Financing

Triumvira Immunologics

Hamilton, Canada · Series A

Biogen

Cambridge, United States

Willow Biosciences

Calgary, Canada · Post IPO Equity

Illumina

San Diego, United States

AbCellera

Vancouver, Canada

Virogin Biotech

Vancouver, Canada · Series D

Genevant Sciences

Vancouver, Canada

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.